Degnan Chris

US insider· US
Sign in for alerts
  • ACQUIREDT+2

    UroGen Pharma Ltd · NASDAQ

    +4,483 sh

    Filed 9 Oct 2026SEC Form 4view source
  • REDUCEDT+2

    UroGen Pharma Ltd · NASDAQ

    −2,202 sh · $80.8K

    Filed 9 Oct 2026SEC Form 4view source